2019 | 2018 | 2017 | 2016 | 2015

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress

11/03/16

SAN DIEGO--(BUSINESS WIRE)--Nov. 3, 2016-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffe

Read More

La Jolla Pharmaceutical Company Receives Positive Opinion from European Orphan Committee for LJPC-401

10/24/16

SAN DIEGO--(BUSINESS WIRE)--Oct. 24, 2016-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patien

Read More

La Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC-401

09/07/16

-Conference Call at 9:00 AM Eastern Time on Thursday, September 8, 2016 SAN DIEGO--(BUSINESS WIRE)--Sep. 7, 2016-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development o

Read More

La Jolla Pharmaceutical Company Reports Positive Results from Phase 1 Study of LJPC-401

09/07/16

-Dose-dependent, Statistically Significant Reduction in Serum Iron Observed (p=0.008) -LJPC-401 Well Tolerated; No Dose-Limiting Toxicities at Any Dose Level -Conference Call at 9:00 AM Eastern Time on Thur

Read More

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016

08/08/16

SAN DIEGO--(BUSINESS WIRE)--Aug. 8, 2016-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffe

Read More

La Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2016 Global Healthcare Conference

06/06/16

SAN DIEGO--(BUSINESS WIRE)--Jun. 6, 2016-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patient

Read More

La Jolla Pharmaceutical Company Announces First Quarter 2016 Financial Results and Recent Corporate Progress

05/06/16

SAN DIEGO--(BUSINESS WIRE)--May 6, 2016-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffer

Read More

La Jolla Pharmaceutical Company to Provide Corporate Overview at the Cowen and Company 36th Annual Health Care Conference

03/03/16

SAN DIEGO--(BUSINESS WIRE)--Mar. 3, 2016-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patient

Read More

La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2015 Financial Results and Highlights Corporate Progress

02/25/16

SAN DIEGO--(BUSINESS WIRE)--Feb. 25, 2016-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patien

Read More

La Jolla Pharmaceutical Company to Provide Corporate Overview at the 2016 BIO CEO & Investor Conference

01/29/16

SAN DIEGO--(BUSINESS WIRE)--Jan. 29, 2016-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patien

Read More



Print Page Print PageE-mail Page E-mail PageRSS Feeds RSS FeedsE-mail Alerts E-mail AlertsIR Contacts IR Contacts